menu-iconMore mobile-close-icon
Skip Navigation
Skip Navigation
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-10 of 10  
 
2.  
Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 1998 Dec 1 (revised 2014 May 1). NGC:010355
Department of Health and Human Services (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
3.  
4.  
Guidelines for the use of antiretroviral agents in pediatric HIV infection. 1999 Apr (revised 2014 Feb 12). NGC:010239
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]; Department of Health and Human Services (U.S.) - Federal Government Agency [U.S.]. View all guidelines by the developer(s)
5.  
United Kingdom national guideline on the management of Trichomonas vaginalis 2014. 1999 Aug (revised 2014). NGC:010298
British Association for Sexual Health and HIV - Medical Specialty Society. View all guidelines by the developer(s)
6.  
UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011). 2006 Feb (revised 2011 Dec). NGC:008902
British Association for Sexual Health and HIV - Medical Specialty Society. View all guidelines by the developer(s)
7.  
New antiretroviral drugs: maraviroc, raltegravir, etravirine, and rilpivirine. 2008 Apr (revised 2011 Nov). NGC:008821
New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by the developer(s)
8.  
9.  
10.  
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor. 2007 Aug (revised 2010 Aug). NGC:008062
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
1-10 of 10